Dr. Kris Discusses Methotrexate in ALL

Dr Kris From Memorial Sloan-Kettering Cancer Center Discusses Methotrexate in Acute Lymphocytic Leukemia

Mark G. Kris, MD from Memorial Sloan-Kettering Cancer Center discusses Methotrexate in Acute Lymphocytic Leukemia (ALL).

Dr. Kris says that by using a regimen that included high dose methotrexate with leucovorin rescue, the cure rate was improved to over 80%. Using this, which Dr. Kris says has now become a standard of care, more than 80% of children with Acute Lymphocytic Leukemia are cured and that the boost in the cure rate was only by changing how methotrexate is given.